Biotin

Biotin

SCHEMBL693036

NCCCC[C@H](N)C(=O)O.O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Biotin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 6/20 0.72
▸ MEN1 O00255 1/20 0.72
▸ ABL1 P00519 1/20 0.72
▸ LMNA P02545 1/20 0.72
▸ PKM P14618 1/20 0.72
▸ IDE P14735 1/20 0.72
▸ MAPK1 P28482 1/20 0.72
▸ KMT2A Q03164 1/20 0.72
▸ RIN1 Q13671 1/20 0.72
▸ L3MBTL1 Q9Y468 1/20 0.72
▸ HLCS P50747 6/20 0.52
▸ FOLH1 Q04609 2/20 0.48
▸ CA12 O43570 4/20 0.47
▸ CA1 P00915 4/20 0.47
▸ CA2 P00918 4/20 0.47
▸ CA9 Q16790 4/20 0.47
▸ PLG P00747 1/20 0.45
▸ PRSS1 P07477 1/20 0.45
▸ PRSS2 P07478 1/20 0.45
▸ PRSS3 P35030 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biotin SCHEMBL3790437 1.00 TDP1 (0.72) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL1033634 0.98 TDP1 (0.69) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL8011738 0.92 TDP1 (0.77) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL8011736 0.92 TDP1 (0.77) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL770769 0.91 TDP1 (0.71) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL770770 0.90 TDP1 (0.85) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL3425472 0.90 TDP1 (0.85) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL739967 0.90 TDP1 (0.85) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL16653090 0.89 TDP1 (0.83) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL6865574 0.89 TDP1 (0.87) TDP1MEN1ABL1LMNAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117062820-A Method for producing biotin, and L-lysine salt of biotin and method for producing same 株式会社德山 2023-11-14 — — CN claimed
WO-2022202982-A1 METHOD FOR PREPARING BIOTIN, L-LYSINE SALT OF BIOTIN, AND METHOD FOR PREPARING SAME 株式会社トクヤマ 2022-09-29 — — WO claimed
CN-103513026-B Signal amplification type immunofluorescence probe, and preparation method and application thereof WU JIAN 2015-04-29 — — CN claimed
CN-103513026-A Signal amplification type immunofluorescence probe, and preparation method and application thereof WU JIAN 2014-01-15 — — CN claimed
CN-102565383-A Signal amplification type immunofluorescence probe and preparation method and application thereof JIAN WU 2012-07-11 — — CN claimed
CN-117062820-A Method for producing biotin, and L-lysine salt of biotin and method for producing same 株式会社德山 2023-11-14 — — CN disclosed
CN-116121294-A Increasing vegetable oil content by altering negative regulatory factors of acetyl-COA carboxylase 密苏里大学管理者 2023-05-16 — — CN disclosed
WO-2022202982-A1 METHOD FOR PREPARING BIOTIN, L-LYSINE SALT OF BIOTIN, AND METHOD FOR PREPARING SAME 株式会社トクヤマ 2022-09-29 — — WO disclosed
CN-114980906-A Compositions and methods for increasing cell viability and longevity and reducing molecular aging JUVN3控股有限责任公司 2022-08-30 — — CN disclosed
CN-107405377-B Method for disrupting exosome, exosome disruption kit, and method for separating exosome from normal cell 三井化学株式会社 2021-08-06 — — CN disclosed
EP-3287137-B1 METHOD FOR DISRUPTING EXOSOMES, EXOSOME DISRUPTION KIT, AND METHOD FOR SEPARATING EXOSOMES DERIVED FROM NORMAL CELLS MITSUI CHEMICALS INC (JP) 2021-05-05 — — EP disclosed
CN-112179883-A Active fluorescence detection method of humanized silent information regulatory factor 4 贵州医科大学 2021-01-05 — — CN disclosed
EP-0743956-A1 PRETARGETING METHODS AND COMPOUNDS NeoRx (US) 1996-11-27 — — EP disclosed
EP-0736035-A1 PRETARGETING METHODS AND COMPOUNDS NEORX CORPORATION (US) 1996-10-09 — — EP disclosed
EP-0732943-A1 THREE-STEP PRETARGETING METHODS AND COMPOUNDS NEORX CORPORATION (US) 1996-09-25 — — EP disclosed
EP-0683676-A1 DIRECTED BIODISTRIBUTION OF SMALL MOLECULES NEORX CORPORATION (US) 1995-11-29 — — EP disclosed
WO-1995015770-A1 PRETARGETING METHODS AND COMPOUNDS NEORX CORPORATION (US) 1995-06-15 — — WO disclosed
WO-1995015335-A2 PRETARGETING METHODS AND COMPOUNDS NEORX CORPORATION (US) 1995-06-08 — — WO disclosed
WO-1995014493-A1 THREE-STEP PRETARGETING METHODS AND COMPOUNDS NEORX CORPORATION (US) 1995-06-01 — — WO disclosed
WO-1994017829-A1 DIRECTED BIODISTRIBUTION OF SMALL MOLECULES NEORX CORPORATION (US) 1994-08-18 — — WO disclosed
Send feedback